Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MiNK Therapeutics, Inc. | Director | Common Stock | 150K | $110K | $0.73 | Dec 1, 2024 | Direct |
INVO Bioscience, Inc. | Director | Stock Option (right to buy) | 85K | May 18, 2023 | Direct | ||
Azitra Inc | Director | Stock Options (Right To Buy) | 10K | Sep 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INKT | MiNK Therapeutics, Inc. | Dec 1, 2024 | 1 | $17.7K | 4 | Dec 3, 2024 | Director |
INKT | MiNK Therapeutics, Inc. | Sep 3, 2024 | 1 | $17.8K | 4 | Sep 5, 2024 | Director |
INKT | MiNK Therapeutics, Inc. | Jun 3, 2024 | 1 | $17.7K | 4 | Jun 5, 2024 | Director |
INKT | MiNK Therapeutics, Inc. | Mar 1, 2024 | 1 | $17.8K | 4 | Mar 5, 2024 | Director |
INKT | MiNK Therapeutics, Inc. | Dec 1, 2023 | 1 | $17.8K | 4 | Dec 5, 2023 | Director |
AZTR | Azitra Inc | Sep 8, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
INKT | MiNK Therapeutics, Inc. | Sep 1, 2023 | 1 | $17.8K | 4 | Sep 6, 2023 | Director |
AZTR | Azitra Inc | Jun 15, 2023 | 0 | $0 | 3 | Jun 15, 2023 | Director |
INKT | MiNK Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
INKT | MiNK Therapeutics, Inc. | Jun 1, 2023 | 1 | $17.8K | 4 | Jun 2, 2023 | Director |
INVO | INVO Bioscience, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
INKT | MiNK Therapeutics, Inc. | Mar 1, 2023 | 1 | $17.8K | 4 | Mar 3, 2023 | Director |
INKT | MiNK Therapeutics, Inc. | Dec 1, 2022 | 1 | $17.8K | 4 | Dec 5, 2022 | Director |
INKT | MiNK Therapeutics, Inc. | Sep 15, 2022 | 1 | $35.5K | 4 | Sep 19, 2022 | Director |
INVO | INVO Bioscience, Inc. | Jun 1, 2022 | 1 | $10K | 4 | Jun 3, 2022 | Director |
INKT | MiNK Therapeutics, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Director |
INVO | INVO Bioscience, Inc. | Jan 15, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
INKT | MiNK Therapeutics, Inc. | Oct 13, 2021 | 0 | $0 | 3 | Oct 20, 2021 | Director |